Hormonal contraception and its role for the maintenance of reproductive potential in women with pelvic inflammatory disease
<b>Hormonal contraception and its role for the maintenance of reproductive potential in women with pelvic inflammatory disease<br> </b><br> M.S. Selikhova, P.A. Soltys, A.A. Smol’yaninov<br> <br> Volgograd State Medical University, Volgograd, Russian Federatio...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LCC «Medicine-Inform»
2019-07-01
|
| Series: | РМЖ. Мать и дитя |
| Online Access: | http://wchjournal.com/upload/iblock/269/2694851a8cb7b31e7c61a55ab0ab7045.pdf |
| Summary: | <b>Hormonal contraception and its role for the maintenance of reproductive potential in women with pelvic inflammatory disease<br>
</b><br>
M.S. Selikhova, P.A. Soltys, A.A. Smol’yaninov<br>
<br>
Volgograd State Medical University, Volgograd, Russian Federation<br>
<br>
<b>Aim</b>: To study the effect of pelvic inflammatory disease (PID) on female reproductive functions and the importance of hormonal contraception for the rehabilitation of these women.<br>
<b>Patients and Methods:</b> The study included two steps. During step 1, 117 women with acute manifestations of PID were examined. These women were subdivided into 2 groups. Group 1 included 36 women (30.8%) with acute PID diagnosed for the first time. Group 2 included 81 women with exacerbations of chronic PID (69.2%). During step 2, the effects of combined oral contraceptive pills (COCPs) on the rehabilitation of 87 women were analyzed.<br>
<b>Results</b>: Our findings demonstrate that PID is diagnosed in the active reproductive age (29.4±4.9 years). In a half of these women, reproductive function was not realized. Adequate antibiotic therapy considering antibiotic susceptibility does not provide complete rehabilitation after the disease. In the second stage 87 women took part, 21 of them women received COCPs (Midiana<sup>®</sup>) for a year after PID, 47 — for 6 months, 8 — for 3 months, 11 — did not received COCs. In 3 women who did not received COCPs (27.3%), inflammation has exacerbated. Menstrual disorders were reported in 5 women (45.5%).<br>
<b>Conclusions</b>: Combined single-phase low-dose contraceptive containing 30 μg of ethinylestradiol and 3 mg of drospirenone (Midiana<sup>®</sup>) provides rehabilitation after PID thus preventing PID recurrences within a year, regaining regular menstrual cycle, and restoring reproductive potential.<br>
<br>
<b>Keywords</b>: active reproductive age, pelvic inflammatory disease, rehabilitation, single-phase low-dose contraceptive, decrease in recurrence rate, regaining menstrual cycle, contraception.<br>
<b>For citation:</b> Selikhova M.S., Soltys P.A., Smol’yaninov A.A. Hormonal contraception and its role for the maintenance of reproductive potential in women with pelvic inflammatory disease. Russian Journal of Woman and Child Health. 2019;2(2):102–106.<br> |
|---|---|
| ISSN: | 2618-8430 2686-7184 |